CloudLIMS Accelerates Monkeypox Virus Testing with its Preconfigured Out-of-the-Box Diagnostics LIMS
11/10/2022

CloudLIMS is pleased to announce that its already versatile, quick-to-deploy LIMS is preconfigured for Monkeypox testing.

Online PR News – 10-November-2022 – Wilmington, Delaware – CloudLIMS, a SOC 2 compliant and ISO 9001:2015 certified laboratory informatics provider, is pleased to announce that its already versatile, quick-to-deploy LIMS is preconfigured for Monkeypox testing. As of October 25, 2022, the Centers for Disease Control and Prevention (CDC) reported 75,885 confirmed or probable monkeypox cases in over 109 locations across the globe. The demand for laboratory tests for Monkeypox is increasing and is expected to continue this trend. Reinforcing its commitment to offering an all-inclusive, secure, and configurable LIMS to clinical diagnostics, CloudLIMS can now automate Monkeypox virus testing and generate compliant reports while maintaining the confidentiality of patient data.

In the same way as its response to the COVID-19 pandemic, CloudLIMS has pre-configured its diagnostics LIMS to provide out-of-the-box support to clinical diagnostic laboratories that have been processing more and more monkeypox samples since infections surged worldwide. CloudLIMS includes FDA and CDC approved tests, workflows, interpretation rules, and reporting templates to maximize testing and reporting capabilities while offering accurate testing with fast turnaround times. It can be deployed in any clinical diagnostic laboratory within a week.

CloudLIMS can be seamlessly configured to support new and future assays, test methods, Standard Operating Procedures (SOPs), and meet reporting requirements for monkeypox and any infectious diseases that follow. All of this prevents costly and time-consuming customization while enhancing the operational efficiency of laboratories.

CloudLIMS’ Monkeypox LIMS leverages digital scanning to process test samples, addresses staffing issues through automation, and enables laboratories to optimally utilize laboratory resources. Furthermore, it monitors and records a sample’s journey from its reception at a laboratory to the end of its life cycle, tracking the genealogy of each specimen at all times. CloudLIMS can be integrated with diagnostic instruments for the automatic transfer of test results as soon as sample testing is complete, thereby eliminating the risk of human error and preserving data integrity.

Another innovative addition that CloudLIMS introduces is the physician portal that allows physicians or providers to place diagnostic test requests, track the status of requests in real-time, download test reports, and significantly improve turnaround time. Moreover, it includes a comprehensive, HIPAA-compliant, secure, cloud-based patient portal, enabling Monkeypox testing laboratories to offer direct-to-patient services and securely deliver test reports to patients.

“Just like COVID-19 testing, CloudLIMS has been waiting for this new platform functionality for Monkeypox testing to come on board to assist laboratories to scale up testing throughput with automation while meeting quality and regulatory standards,” said Arun Apte, Chief Executive Officer at CloudLIMS. “By supporting Monkeypox testing, we want to further our effort to help the healthcare community and laboratories during public health emergencies,” he concluded.

About CloudLIMS:
CloudLIMS.com offers a secure, in the cloud, SaaS LIMS purpose-built for clinical research and diagnostic labs. CloudLIMS offers a range of complimentary services, including technical support and training, instrument integration, legacy data migration, product configuration, automatic product upgrades, hosting, & data backups. CloudLIMS helps labs maintain user access for PHI control, manage clinical data, automate workflows, and meet compliance such as CLIA, HIPAA, ISO 15189, EU GDPR. CloudLIMS.com is a SOC 2 compliant and ISO 9001:2015 certified informatics company.